These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9076757)

  • 1. Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats.
    Pearl SM; Maisonneuve IM; Glick SD
    Neuropharmacology; 1996; 35(12):1779-84. PubMed ID: 9076757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.
    Maisonneuve IM; Keller RW; Glick SD
    Eur J Pharmacol; 1991 Jun; 199(1):35-42. PubMed ID: 1893925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.
    Maisonneuve IM; Glick SD
    Eur J Pharmacol; 1999 Oct; 383(1):15-21. PubMed ID: 10556676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine release and metabolism in nucleus accumbens and striatum of morphine-tolerant and nontolerant rats.
    Johnson DW; Glick SD
    Pharmacol Biochem Behav; 1993 Oct; 46(2):341-7. PubMed ID: 8265688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum.
    Glick SD; Kuehne ME; Raucci J; Wilson TE; Larson D; Keller RW; Carlson JN
    Brain Res; 1994 Sep; 657(1-2):14-22. PubMed ID: 7820611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens.
    Taraschenko OD; Shulan JM; Maisonneuve IM; Glick SD
    Synapse; 2007 Jul; 61(7):547-60. PubMed ID: 17447255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacological characterization of local ibogaine effects on dopamine release.
    Reid MS; Hsu K; Souza KH; Broderick PA; Berger SP
    J Neural Transm (Vienna); 1996; 103(8-9):967-85. PubMed ID: 9013390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
    Borg PJ; Taylor DA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):582-8. PubMed ID: 9151296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic dose-related effects of morphine on dopamine release.
    Maisonneuve IM; Warner LM; Glick SD
    Drug Alcohol Depend; 2001 Dec; 65(1):55-63. PubMed ID: 11714590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Handling and/or saline injections alter basal and morphine-evoked changes in dopamine metabolites in the striatum and nucleus accumbens of rats.
    Johnson DW; Glick SD
    Pharmacol Biochem Behav; 1994 Mar; 47(3):765-8. PubMed ID: 8208798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of morphine applied by intrapallidal microdialysis on the release of dopamine in the nucleus accumbens.
    Anagnostakis Y; Spyraki C
    Brain Res Bull; 1994; 34(3):275-82. PubMed ID: 8055351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation.
    Pearl SM; Johnson DW; Glick SD
    Psychopharmacology (Berl); 1995 Oct; 121(4):470-5. PubMed ID: 8619010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.
    Maisonneuve IM; Rossman KL; Keller RW; Glick SD
    Brain Res; 1992 Mar; 575(1):69-73. PubMed ID: 1504783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Eur J Pharmacol; 2000 Jun; 398(2):259-62. PubMed ID: 10854838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats.
    Di Giannuario A; Pieretti S; Catalani A; Loizzo A
    Neurosci Lett; 1999 Sep; 272(3):183-6. PubMed ID: 10505611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats.
    Narita M; Takagi M; Aoki K; Kuzumaki N; Suzuki T
    J Neurochem; 2003 Jul; 86(2):273-82. PubMed ID: 12871568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.
    Sershen H; Harsing LG; Hashim A; Lajtha A
    Life Sci; 1992; 51(13):1003-11. PubMed ID: 1522749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats.
    Glick SD; Maisonneuve IM; Visker KE; Fritz KA; Bandarage UK; Kuehne ME
    Psychopharmacology (Berl); 1998 Oct; 139(3):274-80. PubMed ID: 9784085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions with D-amphetamine.
    Glick SD; Rossman K; Wang S; Dong N; Keller RW
    Brain Res; 1993 Nov; 628(1-2):201-8. PubMed ID: 8313148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibogaine and the dopaminergic response to nicotine.
    Maisonneuve IM; Mann GL; Deibel CR; Glick SD
    Psychopharmacology (Berl); 1997 Feb; 129(3):249-56. PubMed ID: 9084063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.